logo logo
Search: Organ site Search: Tumor / Syndrome
WHO Classification of Tumours
Chronic myelogenous leukaemia, BCR-ABL1 positive
Tumours of haematopoietic and lymphoid tissues


Chronic myelogenous leukaemia (CML) is a myeloproliferative neoplasm that originates in an abnormal pluripotent bone marrow (BM) stem cell and is consistently associated with the BCR-ABL1 fusion gene located in the Philadelphia (Ph) chromosome
Click to access Pubmed
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M (1983)
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.
Nature 306: 277-80

Click to access Pubmed
Melo JV, Barnes DJ (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
Nat Rev Cancer 7: 441-53

Click to access Pubmed
Nowell PC , Hungerford DA (1960)
A minutre chromosome in human chronic granulocytic leukemia.
Science 132: 14971500.

Click to access Pubmed
Rowley JD (1973)
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.
Nature 243: 290-3

. Although the initial major finding is neutrophilic leukocytosis, the BCR-ABL1 is found in all myeloid lineages as well as in some lymphoid cells and endothelial cells. The natural history of untreated CML is bi- or triphasic: an initial indolent chronic phase (CP) is followed by an accelerated phase (AP), a blast phase (BP) or both.

> Related Topics
Atypical chronic myeloid leukaemia, BCR-ABL1 negative
Chronic neutrophilic leukaemia
Chronic myelomonocytic leukaemia
B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2);BCR-ABL1
Introduction: Myeloid Neoplasms